GLS and glioblastoma: The diminishing expression or activity of GLS isoforms significantly decreased the proliferation of the prostate cancer cells [9], leukemic cells [13], Ehrlich ascites tumor cells [14], breast cancer cells [10,15], and glioblastoma cells [11,16].